[GUIMIT 2019, Mexican Guideline on Immunotherapy. Guideline on the diagnosis of IgE-mediated allergic disease and immunotherapy following the ADAPTE approach]. / GUIMIT 2019, Guía Mexicana de Inmunoterapia. Guía de diagnóstico de alergia mediada por IgE e inmunoterapia aplicando el método ADAPTE.

BACKGROUND: In Mexico, allergen immunotherapy (AIT) and immunotherapy with hymenoptera venom (VIT) is traditionally practiced combining aspects of the European and American school. In addition, both types of extracts (European and American) are commercially available in Mexico. Moreover, for an adequate AIT/VIT a timely diagnosis is crucial. Therefore, there is a need for a widely accepted, up-to-date national immunotherapy guideline that covers diagnostic issues, indications, dosage, mechanisms, adverse effects and future expectations of AIT (GUIMIT 2019). METHOD: With nationwide groups of allergists participating, including delegates from postgraduate training-programs in Allergy/Immunology-forming, the guideline document was developed according to the ADAPTE methodology: the immunotherapy guidelines from European Academy of Allergy and Clinical Immunology, German Society for Allergology and Clinical Immunology, The American Academy of Allergy, Asthma and Immunology and American College of Allergy, Asthma, and Immunology were selected as mother guidelines, as they received the highest AGREE-II score among international guidelines available; their evidence conforms the scientific basis for this document. RESULTS: GUIMIT emanates strong or weak (suggestions) recommendations about practical issues directly related to in vivo or in vitro diagnosis of IgE mediated allergic diseases and the preparation and application of AIT/VIT and its adverse effects. GUIMIT finishes with a perspective on AIT modalities for the future. All the statements were discussed and voted on until > 80 % consensus was reached. CONCLUSIONS: A wide and diverse group of AIT/VIT experts issued transculturized, evidence-based recommendations and reached consensus that might improve and standardize AIT practice in Mexico.

Antecedentes: En México, la inmunoterapia con alérgenos (ITA) y con veneno de himenópteros (VIT) se practica tradicionalmente combinando criterios de las escuelas europea y estadounidense; los dos tipos de extractos están comercialmente disponibles en México. Para una ITA adecuada es crucial un diagnóstico oportuno. Objetivo: Presentar GUIMIT 2019, Guía Mexicana de Inmunoterapia 2019, de base amplia, actualizada, que abarca temas de diagnóstico, indicaciones, dosificación, mecanismos, efectos adversos de la ITA y expectativas con esta modalidad de tratamiento. Método: Con la participación de múltiples grupos mexicanos de alergólogos, que incluían los centros formadores universitarios en alergia e inmunología, se desarrolló el documento de la guía según la metodología ADAPTE. Las guías de inmunoterapia de la European Academy of Allergy and Clinical Immunology, The American Academy of Allergy, Asthma and Immunology, German Society for Allergology and Clinical Immunology y del American College of Allergy, Asthma, and Immunology se seleccionaron como guías fuente, ya que recibieron la puntuación AGREE-II más alta entre las guías internacionales disponibles; su evidencia conforma la base científica de GUIMIT 2019. Resultados: En GUIMIT 2019 se emiten recomendaciones fuertes o débiles (sugerencias) acerca de temas directamente relacionados con el diagnóstico in vivo o in vitro de las enfermedades alérgicas mediadas por IgE, la preparación y aplicación de ITA o VIT y sus efectos adversos; se incluye la revisión de las modalidades de ITA para el futuro. Todos los argumentos que se exponen fueron discutidos y votados con > 80 % de aprobación. Conclusión: Un grupo amplio y diverso de expertos en ITA y VIT emitió recomendaciones transculturizadas basadas en evidencia, que alcanzaron consenso; con ellas se pretende mejorar y homologar la práctica de la inmunoterapia en México.

Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.

OBJECTIVES: To establish an evidence-based cut-off to differentiate between early and late recurrence and to compare clinicopathologic risk factors between the two groups. SUMMARY BACKGROUND DATA: A clear definition of "early recurrence" after pancreatic ductal adenocarcinoma resection is currently lacking. METHODS: Patients undergoing pancreatectomy for pancreatic ductal adenocarcinoma between 2000 and 2013 were included. Exclusion criteria were neoadjuvant therapy and incomplete follow-up. A minimum P-value approach was used to evaluate the optimal cut-off value of recurrence-free survival to divide the patients into early and late recurrence cohorts based on subsequent prognosis. Potential risk factors for early recurrence were assessed with logistic regression models. RESULTS: Of 957 included patients, 204 (21.3%) were recurrence-free at last follow-up. The optimal length of recurrence-free survival to distinguish between early (n = 388, 51.5%) and late recurrence (n = 365, 48.5%) was 12 months (P < 0.001). Patients with early recurrence had 1-, and 2-year post-recurrence survival rates of 20 and 6% compared with 45 and 22% for the late recurrence group (both P < 0.001). Preoperative risk factors for early recurrence included a Charlson age-comorbidity index ≥4 (OR 1.65), tumor size > 3.0 cm on computed tomography (OR 1.53) and CA 19-9 > 210 U/mL (OR 2.30). Postoperative risk factors consisted of poor tumor differentiation grade (OR 1.66), microscopic lymphovascular invasion (OR 1.70), a lymph node ratio > 0.2 (OR 2.49), and CA 19-9 > 37 U/mL (OR 3.38). Adjuvant chemotherapy (OR 0.28) and chemoradiotherapy (OR 0.29) were associated with a reduced likelihood of early recurrence. CONCLUSION: A recurrence-free interval of 12 months is the optimal threshold for differentiating between early and late recurrence, based on subsequent prognosis.

A Mucinous Cystic Neoplasm Originating from the Gallbladder: A Case Report and Literature Review.

INTRODUCTION: Mucinous cystic neoplasms of the gallbladder are extremely rare, benign, unilocular or multilocular cystic tumors that contain septations. Mucinous cystadenoma, a subtype of mucinous cystic neoplasm, is defined as epithelial cystic proliferations composed of cells that contain intracytoplasmic mucin. CASE PRESENTATION: A 70-year-old African American woman was admitted to the hospital because of progressive lower back pain and inability to walk. She was scheduled for a kyphoplasty. However, the day before surgery, she reported severe abdominal pain radiating to her right shoulder. On further workup, results of abdominal ultrasonography revealed a cystic mass in the lumen of the gallbladder. The kyphoplasty was postponed and a laparoscopic cholecystectomy was performed. Pathologic evaluation of the gallbladder revealed a multiloculated mucinous cystic neoplasm. DISCUSSION: Mucinous cystadenoma of the gallbladder account for 0.02% of the total number of cases in the hepatobiliary system. They are more frequently seen in middle-age women with a mean age at presentation of 45 years. Symptoms vary depending on the location of the tumor, but it typically presents as acute or chronic right upper quadrant pain, epigastric pain, and nausea and vomiting. The multilocular form is more common than unilocular. The cystic lesions can be filled with serous, hemorrhagic, mucinous, or mixed fluids. Clinicians should be suspicious of mucinous cystadenoma of the gallbladder when common gallbladder disease is excluded because malignant features can be present in the lesion.

An Interview with Dr. John L. Cameron, the Hall of Famer of Pancreatic Cancer.

The Society of Surgical Alimentary Tract (SSAT) Resident Education Committee aim is to facilitate resident participation in the annual meeting and foster the education of the next generation of gastrointestinal. The SSAT "Residents Corner" was developed as a video-blog highlighting areas of interest for surgical trainees looking to focus on a career in gastrointestinal surgery. The topics covered are to make surgical education more accessible, one way is to highlight leaders in the field who discuss their journey. A 10-min video of a surgical mentor is recorded and archived on the SSAT site under a video series called "Mentor of the Month." A synopsis of a video published online February 2018 featuring Dr. John Cameron interviewed by one of his trainee, Dr. Vanita Ahuja. Dr. Cameron shares his thoughts on his accomplishments, challenges, and advice for young surgeons and the future of pancreatic surgery. The interview offers an insight into the mind of one of the greatest leaders of surgery of our time.

Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.

Candida albicans biofilms play a key role in denture stomatitis, one of the most common oral pathologies in elderly people. Because biofilms are highly resistant to antifungals, new pharmacological strategies are needed. Aspirin and nitric oxide-donor molecules have both shown antibiofilm effects on C. albicans, making them promising candidates for treatment. In this study, we evaluated the antifungal/antibiofilm effect of a nitric-oxide releasing aspirin (NO-ASA) on C. albicans isolates from denture stomatitis patients in vitro. Disk diffusion assays showed that while NO-ASA had no antifungal effect, the drug potentiated fluconazole inhibition zone diameters, increasing the effect of fluconazole by 20-30% (p<0.05). The effect of NO-ASA on the morphogenesis of C. albicans was evaluated using light microscopy after inducing hyphae formation. For all clinical strains assayed, 125 µM NO-ASA significantly decreased the number of filamentous cells present (p<0.01). Adhesion to abiotic surfaces, a critical event for biofilm formation, was evaluated in 96-well polystyrene plates using crystal violet assay; 125 µM NO-ASA significantly inhibited adhesion. Biofilms were observed with scanning electron microscopy (SEM) and quantified using XTT reduction assay. NO-ASA decreased biofilm formation (IC50 ranging from 300 µM to 700 µM), consistent with SEM findings of altered biofilm microarchitecture. PGE2 and carboxy-PTIO (an NO scavenger) both blocked the antibiofilm effects of NO-ASA, suggesting that the efficacy of NO-ASA may be associated with both inhibition of PGE2 synthesis and release of NO. NO-ASA is a promising novel antibiofilm agent for treating fluconazole-resistant strains of C. albicans.

[Knowledge of asthma: educational intervention with the 2014 GINA guide in primary care physicians]. / Conocimiento de asma: intervención educativa con la guía GINA 2014 en médicos de primer contacto.

BACKGROUND: Asthma is a public health problem in the world, so updating the guidelines for the diagnosis and treatment of asthma is based primarily on the practice of primary care physicians. Educational interventions are useful for increasing knowledge. OBJECTIVE: To compare the level of knowledge of asthma before and after an educational intervention. METHODS: A quasi-experimental prospective study was conducted in general and family practitioners and pediatricians who attended a training workshop on general aspects of asthma and current guidelines for diagnosis and treatment (GINA 2014). A questionnaire consisting of 11 multiple choice questions relating to fundamental aspects of the disease and diagnosis, classification, treatment and management of attacks, was used in two assessments, baseline and post-intervention. RESULTS: A total of 178 patients participated in the study, with knowledge pre-intervention at 25.5 points and post-intervention at 97.5 points on a scale of 100, with p < 0.05. CONCLUSION: Educational interventions are inexpensive and effective tools to increase the knowledge of health professionals, and they have an impact on improving patient care.

Introducción: El asma en un problema de salud pública en el mundo, por ello, la actualización de las guías para el diagnóstico y tratamiento de asma se realiza en función principalmente de la práctica de los médicos de primer contacto. Las intervenciones educativas son útiles para el incremento del conocimiento. Objetivo: Comparar el nivel de conocimiento acerca de asma antes y después de una intervención educativa. Métodos: Se realizó un estudio prospectivo cuasiexperimental, en médicos generales, familiares y pediatras que asistieron a un curso-taller relativo a aspectos generales del asma y las guías actuales para su diagnóstico y tratamiento (GINA 2014). Mediante un cuestionario constituido por 11 preguntas de opción múltiple que abordaban aspectos fundamentales de la enfermedad como diagnóstico, clasificación, tratamiento y manejo de exacerbaciones, se realizaron dos evaluaciones, una basal y otra posintervención. Resultados: Un total de 178 paciente participaron en el estudio, con un conocimiento preintervención de 25.5 puntos y posintervención de 97.5 puntos de una escala de 100, con una p<0.05. Conclusión: Las intervenciones educativas son maniobras de bajo costo y efectivas que incrementan el conocimiento de los profesionales de la salud y tienen impacto en la mejoría de la atención al paciente.

Diagnóstico en tomografía computarizada de tumores endobronquiales de estirpe lipomatosa / Computed tomography diagnosis of lipomatous endobronchial tumors lineage

We describe two cases of lipomatous endobronquial tumors diagnosed by CT. The first case showed a homogeneous fat density endobronquial nodule in the right intermediate bronchus compatible with lipoma. The second patient underwent a CT under the suspicion of a endobronquial lesion after two episodes of pneumonia localized in left lower lobe. The TC demonstrated a fat predominant nodule in the left lower lobe bronchus. The anatomopathologic study confirmed a lipomatous hamartoma with areas of mature cartilage.

. Describimos 2 casos de tumores lipomatosos endobronquiales diagnosticados mediante TC. El primer caso mostró un nódulo homogéneo de densidad grasa de 11 mm localizado en el bronquio intermediario derecho, que correspondió a un lipoma. El segundo paciente se sometió a una TC por la sospecha de lesión endobronquial luego que cursara con 2 episodios de neumonías localizadas en el lóbulo inferior izquierdo. En esta se demostró un nódulo de predominio graso con pequeñas áreas de densidad de partes blandas en el bronquio inferior izquierdo. El estudio patológico confirmó que se trataba de un hamartoma lipomatoso con áreas de cartílago maduro.

Coagulation/flocculation-based removal of algal-bacterial biomass from piggery wastewater treatment.

Two conventional chemical coagulants (FeCl3 and Fe2(SO4)3) and five commercial polymeric flocculants (Drewfloc 447, Flocudex CS/5000, Flocusol CM/78, Chemifloc CV/300 and Chitosan) were comparatively evaluated for their ability to remove algal-bacterial biomass from the effluent of a photosynthetically oxygenated piggery wastewater biodegradation process. Chlorella sorokiniana, Scenedesmus obliquus, Chlorococcum sp. and a wild type Chlorella, in symbiosis with a bacterial consortium, were used as model algal-bacterial consortia. While the highest biomass removals (66-98%) for the ferric salts were achieved at concentrations of 150-250 mg L(-1), dosages of 25-50 mg L(-1) were required for the polymer flocculants to support comparable removal efficiencies. Process efficiency declined when the polymer flocculant was overdosed. Biomass concentration did not show a significant impact on flocculation within the concentration range tested. The high flocculant requirements herein recorded might be due to the competition of colloidal organic for the flocculants and the stationary phase conditions of biomass.

A comparative evaluation of microalgae for the degradation of piggery wastewater under photosynthetic oxygenation.

Two green microalgae (Scenedesmus obliquus and Chlorella sorokiniana), one cyanobacterium (Spirulina platensis), one euglenophyt (Euglena viridis) and two microalgae consortia were evaluated for their ability to support carbon, nitrogen and phosphorous removal in symbiosis with activated sludge bacteria during the biodegradation of four and eight times diluted piggery wastewater in batch tests. C. sorokiniana and E. viridis were capable of supporting the biodegradation of four and eight times diluted wastewater. On the other hand, while S. obliquus and the consortia isolated from a swine manure stabilization pond were only able to grow in eight times diluted wastewater, S. platensis and the consortium isolated from a high rate algal pond treating swine manure were totally inhibited regardless of the dilution applied. TOC removal efficiencies (RE) ranging from 42% to 55% and NH(4)(+)-RE from 21% to 39% were recorded in the tests exhibiting photosynthetic oxygenation. The similar oxygen production rates exhibited by the tested microalgae under autotrophic conditions (from 116 to 133mgO(2)L(-1)d(-1)) suggested that factors other than the photosynthetic oxygenation potential governed piggery wastewater biodegradation. Microalgal tolerance towards NH(3) was hypothesized as the key selection criterion. Further studies in a continuous algal-bacterial photobioreactor inoculated with C. sorokiniana, S. obliquus and S. platensis showed that C. sorokiniana, the species showing the highest NH(3)-tolerance, rapidly outcompeted the rest of the microalgae during the biodegradation of eight times diluted wastewater, achieving TOC and NH(4)(+)-RE comparable to those recorded in the batch biodegradation tests.

Factores asociados con la abstinencia y eficacia de un programa de cesación de tabaquismo / Risk factors associated with abstinence. Efficacy of a smoking cessation program

El tabaquismo es la primera causa de morbimortalidad evitable en el mundo occidental. Objetivo: evaluar la eficacia de un programa de cesación de tabaquismo y factores asociados con la cesación. Material y método: 517 individuos ingresaron al programa, 357 completaron al menos dos sesiones. Se consignó: sexo, edad, estado civil, nivel de educación, enfermedades asociadas, entorno familiar de fumadores, intentos previos para dejar de fumar, historia de tabaquismo y grado de dependencia por escala de Fagerstrõm. Se aplicó un programa de ocho semanas multicomponente: cognitivo-conductual, farmacológico (bupropión o terapia de reemplazo nicotínico) y terapia grupal. La abstinencia fue confirmada por medida del CO exhalado. Resultados: los individuos tuvieron una edad entre 20 y 77 años (media de 50,58 ± 11,24), fueron 61,1 por ciento mujeres, 82,9 por ciento con intentos previos para dejar de fumar, fumadores de 44,22 ± 26,30 paquetes/año, edad de inicio media de 17,93 ± 3,65 años, consumo de 28,38 ± 13,45 cigarrillos/día, dependencia por Fagerstrõm de 5,99 ± 2,12, 89,4 por ciento recibieron medicación; 113 participantes (31,6 por ciento) se mantuvieron sin fumar al año. Un menor índice de cesación se asoció significativamente con: sexo femenino, mayor dependencia por escala de Fagerstrõm, y seguir fumando en las primeras semanas y a los tres meses de inicio del programa. Conclusiones: se comprobó la eficacia del programa con una tasa de cesación al año de 31,6 por ciento, comparable con los datos publicados por otros centros y asociada al género, la dependencia a la nicotina y el cese precoz, al inicio del programa.

Smoking and inflammatory bowel disease: a meta-analysis.

OBJECTIVE: To assess whether there is a true effect of smoking on the 2 most prevalent forms of inflammatory bowel disease (IBD): Crohn disease (CD) and ulcerative colitis (UC). METHODS: For this meta-analysis, we searched multiple health care databases, including MEDLINE and EMBASE (January 1980 to January 2006), to examine the relationship between smoking and IBD. Keywords searched included smoking, Inflammatory bowel disease, Crohn's disease, and ulcerative colitis. Data were abstracted using predefined inclusion and exclusion criteria. An odds ratio (OR) was recalculated for each study using the random-effects model, and a combined OR was calculated. RESULTS: A total of 245 articles were obtained through an electronic search of health care databases. Thirteen studies examined the relationship between UC and smoking, whereas 9 examined the relationship between CD and smoking. We found evidence of an association between current smoking and CD (OR, 1.76; 95% confidence interval [CI], 1.40-2.22) and former smoking and UC (OR, 1.79; 95% CI, 1.37-2.34). Current smoking had a protective effect on the development of UC when compared with controls (OR, 0.58; 95% CI, 0.45-0.75). CONCLUSION: This is the first meta-analysis, to our knowledge, to evaluate the relationship between smoking and IBD using accepted quality standards for meta-analysis reporting. Our meta-analyses confirm that smoking is an important environmental factor in IBD with differing effects in UC and CD. By using predefined inclusion criteria and testing for homogeneity, the current analysis provides an estimate of the effect of smoking on both these forms of IBD.

Mortalidad asociada al traumatismo craneoencefálico / Associated mortality to cranioencephalic traumatism

En este trabajo se analizaron en forma retrospectiva los pacientes que ingresaron a la unidad de neurocirugía de nuestro Hospital Calderón Guardia durante el período comprendido entre el primero de enero y el 31 de diciembre de 1997 con diagnóstico de trauma craneoencefálico severo (Glasgow 3-8). Reunieron estos requisitos 16 pacientes. La causa principal de ingreso fue el accidente de tránsito. La relación hombre mujer fue de 3:1. La edad estuvo en los rangos de 15 a 53 años, siendo el grupo más afectado entre 12 a 20 años. Todos presentaron lesión intracraneana demostrada por TC, dentro de las cuales, las más frecuentes fueron hemorragia subaracnoidea, las contusiones múltiples y el edema cerebral. Se presentaron lesiones asociadas siendo la más frecuente las fracturas de miembros superiores. De las complicaciones intrahospitalarias la más frecuente fue la infección pulmonar. La mortalidad fue del 18.75 por ciento, tomando en cuenta que se tuvieron criterios de inclusión muy estrictos. Un 62 por ciento de los pacientes tuvieron una recuperación muy satisfactoria demostrada con una escala de Glasgow al salir de 14-15 puntos.

Colecistectomía laparoscópica: experiencia de 851 casos / Laparoscopic cholecystectomy: experience with 851 cases

Se practicaron 851 colecistectomía laparoscópica desde Enero de 1991 hasta Febrero de 1996. Se convirtieron 25 casos (2.9 por ciento) a cirugía abierta: 17(2 por ciento) debido a anatomía compleja, 4 debido a hemorragia, 3 por lesión de duodeno. Se presentaron 146 casos de colecistitis aguda (17.2 por ciento) y 705 de colecistitis crónicas (82.8 por ciento). Se llevaron a cabo 20 colangiografías operatorias selectivas (2.3 por ciento), de las cuales 5 resultaron positivas (2 casos manejados con colangiopancreatografía retrógada endoscópica [CPRE] post operatoria, en dos casos se extrajeron los cálculos per operatoriamente con cesta de Dormia y en un caso se avanzó instrumentalmente al duodeno. Treinta y ocho pacientes desarrollaron complicaciones (4.5 por ciento): 8 operatorias (0.9 por ciento), 3 post operatorias mayores (0.3 por ciento) y 27 post operatorias menores (3.1 por ciento). La complicación más frecuente fue la infección umbilical (n=27,3.1 por ciento). No se presentaron muertes en este estudio